< Back to previous page
Researcher
Johan Maertens
- Disciplines:Biochemistry and metabolism, Microbiology, Systems biology, Laboratory medicine, Medical biochemistry and metabolism
Affiliations
- Laboratory of Clinical Microbiology (Division)
Member
From1 Oct 2014 → Today - Department of Microbiology, Immunology and Transplantation (Department)
Member
From1 Oct 2013 → 30 Sep 2014 - Woman and Child (Division)
Member
From1 Apr 2013 → 30 Sep 2013
Projects
1 - 10 of 11
- Insights in febrile neutropenia (SAFE study) and clinical and translational insights in (invasive) mold infections and mycology, with the focus on Hematologic patients.From1 Oct 2023 → TodayFunding: Own budget, for example: patrimony, inscription fees, gifts
- Optimization and validation of collateral sensitivity based alternative treatment strategies for multidrug resistant CandidemiaFrom1 Oct 2022 → TodayFunding: IOF - technology validation in lab
- SAFE study: a randomized non-inferiority trialFrom1 Oct 2022 → TodayFunding: Foundations, funds and other with scientific goal
- Improving prevention and treatment strategies concerning opportunistic infections in immunocompromised hematologic patientsFrom14 Sep 2020 → TodayFunding: Foundations, funds and other with scientific goal
- Clonal evolution and biology of co-operative oncogenic events in acute lymphoblastic leukemia.From1 Oct 2018 → 30 Sep 2023Funding: Fund Recuperation Fiscal Exemption
- Fast diagnosis of opportunistic respiratory infections trough exhaled breath analysisFrom1 Oct 2017 → 30 Sep 2020Funding: FWO Applied Biomedical Research (TBM)
- Triazole-resistance in Aspergillus fumigatus: evolving epidemiology and influence on disease progression.From15 Mar 2017 → 2 Dec 2021Funding: BOF - doctoral mandates, BOF - Doctoral projects
- Faster to the fungus: rapid diagnostic and prognostic tests for invasive fungal diseasesFrom1 Aug 2016 → 9 Oct 2020Funding: Own budget, for example: patrimony, inscription fees, gifts
- Rethinking 'Care after Cure' in allogeneic hematopoietic stem cell transplantation using e-Health and patient reported outcomesFrom1 Sep 2015 → 14 Nov 2019Funding: Own budget, for example: patrimony, inscription fees, gifts
- Assessment of the impact of emerging azole resistance mechanisms on treatment response of invasive pulmonary aspergillosis using non-invasive imaging in experimental Aspergillus infection models.From1 Jan 2015 → 31 Dec 2018Funding: FWO research project (including WEAVE projects)
Publications
31 - 40 of 536
- AUTOLOGOUS PERIPHERAL BLOOD STEM CELL MOBILISATION TECHNIQUES, CELL YIELDS AND PRACTICE VARIATION-BYCOUNTRY IN MYELOMA PATIENTS UNDERGOING FIRST AUTOLOGOUS STEM CELL TRANSPLANTS IN EBMT CENTRES (2012-2021)(2023)
Authors: Johan Maertens
Pages: 602 - 603 - INCIDENCE AND RISK FACTORS OF GRAFT FAILURE AFTER CORD BLOOD HEMATOPOIETIC STEM CELL TRANSPLANTATION IN CHILDREN WITH MUCOPOLYSACCHARIDOSIS : A SFGM-TC RETROSPECTIVE MULTICENTER STUDY(2023)
Authors: Johan Maertens
Pages: 358 - 359 - Gut microbiota alterations induced by intensive chemotherapy in acute myeloid leukaemia patients are associated with gut barrier dysfunction and body weight loss(2023)
Authors: Johan Maertens
Pages: 2214 - 2228 - OUTCOMES AFTER ANTI-BCMA CAR T-CELLS FOR MULTIPLE MYELOMA, A RETROSPECTIVE ANALYSIS ON BEHALF OF THE CTIWP OF THE EBMT(2023)
Authors: Johan Maertens
Pages: 194 - 195 - OUTCOMES OF CMML PATIENTS UNDERGOING ALLOGENEIC HCT IN COMPARISON WITH MDS PATIENTS - A RETROSPECTIVE ANALYSIS ON BEHALF OF THE CMWP OF THE EBMT(2023)
Authors: Johan Maertens
Pages: 48 - 49 - INFLUENCE OF PRE-EXISTING INVASIVE ASPERGILLOSIS ON ALLO-HSCT OUTCOME IN ACUTE LEUKEMIA PATIENTS: A PROSPECTIVE STUDY OF THE EBMT INFECTIOUS DISEASES WORKING PARTY(2023)
Authors: Johan Maertens
Pages: 85 - 86 - IMPACT OF BUSULFAN, ETOPOSIDE AND HIGH-DOSE ARA-C (BEA) CONDITIONING FOR AUTOLOGOUS STEM CELL TRANSPLANTATION IN AML(2023)
Authors: Johan Maertens
Pages: 57 - 57 - VALIDATION IN A CONTEMPORARY ELDERLY POPULATION OF THE TRANSPLANT CONDITIONING INTENSITY (TCI) SCORE FOR ALLOGENEIC HEMATOPOIETIC CELL TRANSPLANTATION(2023)
Authors: Johan Maertens
Pages: 54 - 55 - COMPARATIVE STUDY FOR HAPLO-, MSD AND MUD ALLOHCTS FOR AML PATIENTS WITH KMT2A REARRANGEMENT: A STUDY ON BEHALF OF THE EBMT GLOBAL COMMITTEE AND ALWP(2023)
Authors: Johan Maertens
Pages: 29 - 30 - Current incidence, severity, and management of veno-occlusive disease/sinusoidal obstruction syndrome in adult allogeneic HSCT recipients: an EBMT Transplant Complications Working Party study(2023)
Authors: Hélène Schoemans, Johan Maertens
Pages: 1209 - 1214